Compounded Bioidentical Menopausal Hormone Therapy
Publication Date: November 1, 2023
Last Updated: January 19, 2024
Summary of Consensus Recommendations
Safety and Efficacy of Custom-Compounded Hormone Therapy
There is a lack of high-quality data on the safety and efficacy of custom-compounded bioidentical hormone therapy for the management of menopausal symptoms. Compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist.
6731
Title
Compounded Bioidentical Menopausal Hormone Therapy
Authoring Organization
American College of Obstetricians and Gynecologists